Acasti Pharma (CVE:ACST) Shares Climb 1.8% – Here’s Why

Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares traded up 1.8% during trading on Tuesday. The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Stock Performance

The company has a market cap of C$18.19 million, a price-to-earnings ratio of -1.21 and a beta of 1.22. The company has a fifty day moving average of C$0.58 and a two-hundred day moving average of C$0.58.

Acasti Pharma Company Profile

(Get Free Report)

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Recommended Stories

Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.